Status:
COMPLETED
Clinical and Biochemical Evaluation of 1% Metformin in Non-surgical Treatment of Periodontitis
Lead Sponsor:
Ain Shams University
Conditions:
Periodontitis
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
The aim of the study to evaluate the clinical and biochemical efficacy of 1% Metformin gel in treatment of periodontitis patients
Eligibility Criteria
Inclusion
- Patients with Stage III Grade A Periodontitis.
- Systemically free according to the modified Burkitt's health history questionnaire, Group I. (Glick et al., 2021).
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program.
Exclusion
- Smokers
- Pregnant and lactating females.
- Vulnerable groups of patients' e.g (prisoners, handicapped patients and decisionally impaired individuals).
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06204185
Start Date
February 1 2019
End Date
November 30 2022
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sameh Magdy Abou El-Kheir
Cairo, Egypt